Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end-stage kidney disease: A national cohort study.
Michael I EllenbogenShirin ArdeshirrouhanifardJodi B SegalMichael B StreiffSteven B DeitelzweigDaniel J BrotmanPublished in: Journal of hospital medicine (2022)
Apixaban was associated with a lower risk of bleeding relative to warfarin when used to treat acute VTE in patients with ESKD on dialysis.
Keyphrases
- venous thromboembolism
- direct oral anticoagulants
- liver failure
- atrial fibrillation
- respiratory failure
- drug induced
- aortic dissection
- randomized controlled trial
- chronic kidney disease
- systematic review
- hepatitis b virus
- quality improvement
- end stage renal disease
- intensive care unit
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome